New Zealand markets open in 7 hours 58 minutes

Cannabis Stocks

Cannabis Stocks

156.90k followers18 symbols Watchlist by Yahoo Finance

Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis

Curated by Yahoo Finance


Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.

How do we pick these stocks?

This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.

How are these weighted?

The stocks on this watchlist are weighted equally at the time they were added.

To learn what every company on this list is doing that involves cannabis, read this story.


WatchlistChange today1-month return1-year returnTotal return
Cannabis Stocks-2.07%+58.10%-9.72%+327.19%

18 symbols

SymbolCompany nameLast priceChange% changeMarket timeVolumeAvg vol (3-month)Market cap
ABBVAbbVie Inc.131.98-1.05-0.79%4:02 pm GMT-57.58M6.57M233.32B
BUDAnheuser-Busch InBev SA/NV65.13-0.46-0.70%4:00 pm GMT-51.43M1.87M114.26B
MOAltria Group, Inc.50.32-0.01-0.02%4:03 pm GMT-58.80M8.68M92.44B
TAPMolson Coors Beverage Company48.62-0.75-1.52%4:00 pm GMT-51.65M1.73M10.57B
SMGThe Scotts Miracle-Gro Company149.23-5.01-3.25%4:00 pm GMT-5327.80k414.82k8.21B
WEED.TOCanopy Growth Corporation9.16-0.30-3.17%4:00 pm GMT-52.66M2.39M3.61B
CGCCanopy Growth Corporation7.29-0.27-3.57%4:00 pm GMT-57.22M7.68M2.88B
TLRYTilray Brands, Inc.5.79-0.13-2.20%4:00 pm GMT-525.14M24.09M2.70B
CRONCronos Group Inc.3.43-0.14-3.92%4:00 pm GMT-52.67M3.38M1.28B
ACBAurora Cannabis Inc.4.46-0.29-6.11%4:00 pm GMT-56.45M5.58M886.26M
NBEVNewAge, Inc.0.7299-0.01-0.98%4:00 pm GMT-51.12M1.55M107.16M
CRBPCorbus Pharmaceuticals Holdings, Inc.0.467-0.04-8.57%4:00 pm GMT-51.15M1.08M58.48M
TGODFThe Green Organic Dutchman Holdings Ltd.0.07715-0.00-5.91%3:57 pm GMT-5926.55k854.96k42.92M
CANNGeneral Cannabis Corp0.3202-0.01-2.02%3:31 pm GMT-5157.94k153.12k27.15M
MJETFMG Alternative Harvest ETF9.77-0.35-3.46%4:00 pm GMT-51.67M1.44M-
  • Motley Fool

    Is AbbVie Stock a Top Pick for 2022?

    Treasury yields are rising, and the Federal Reserve is expected to raise interest rates multiple times in 2022. In the case of AbbVie (NYSE: ABBV), look no further. AbbVie is a global prescription drug developer, manufacturer, and distributor that was spun off from parent company Abbott Labs back in 2013.

  • Motley Fool

    This Megamerger Might Be Required Before Canadian Cannabis Stocks Can Rebound

    The legal cannabis industry in Canada must continue to consolidate to make it an attractive space for investors.

  • Motley Fool

    3 Clinical Trials to Watch in the First Half of 2022

    In this Motley Fool Live video recorded on Jan. 12, 2022, Fool contributors Keith Speights and Brian Orelli discuss three clinical trials especially worth watching in the first half of 2022. Which clinical results are you especially looking forward to seeing? Brian Orelli: Arena (NASDAQ: ARNA), the ticker there is A-R-N-A, it expects data from a phase 3 study of etrasimod in patients with ulcerative colitis.